China Lymphoma Patient Registry Study
Condition(s):LymphomaLast Updated:October 18, 2017Recruiting
Include Studies Not Open or Pending
Condition(s):LymphomaLast Updated:October 18, 2017Recruiting
Condition(s):LymphomaLast Updated:August 18, 2017Recruiting
Condition(s):Lymphoma; SurvivorshipLast Updated:March 15, 2022Recruiting
Condition(s):Mantle Cell LymphomaLast Updated:November 12, 2021Not yet recruiting
Condition(s):MCL; Mantle Cell LymphomaLast Updated:February 14, 2022Recruiting
Condition(s):Non Hodgkin Lymphoma (NHL)Last Updated:June 26, 2017Recruiting
Condition(s):LymphomaLast Updated:June 8, 2022Not yet recruiting
Condition(s):Peripheral T Cell LymphomaLast Updated:August 4, 2022Recruiting
Condition(s):Diffuse Large B Lymphoma (DLBCL); Follicular Lymphoma (FL); Mantle Cell Lymphoma (MCL); Marginal Zone Lymphoma (MZL); T-cell Lymphoma (T-NHL); Hodgkin’s Lymphoma (HL); Burkitt Lymphoma (BL))Last Updated:June 28, 2021Recruiting
Condition(s):Lymphoma; Hematologic MalignanciesLast Updated:January 4, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.